When peripheral artery disease (PAD) progresses to Chronic Limb-Threatening Ischemia (CLTI), a patient’s options become limited. As the disease evolves to its late stages, patients may no longer be candidates for balloons or stents and may face bypass surgery, or worse, amputation.

However, they are ready to do anything to resolve the pain and regain quality of life.

Enter LimFlow.

In a minimally-invasive fashion, the LimFlow System is designed to bypass blocked arteries in the leg and rush blood back into the foot, potentially avoiding major amputation, resolving pain and promoting wound healing.

The inventiveness of the company has led to a procedure that reimagines the anatomy, turning a vein into an artery and reversing flow to bring blood flow and oxygen back to starved ischemic legs.

The novel LimFlow System employs a variety of proprietary technologies — including ultrasound catheters, a push valvulotome, and crossing and extension stents — to create a new and minimally-invasive option for “no option” CLTI patients that may help them improve their lives and avoid amputation.

LimFlow - Proprietary Crossing Stents System

Product Details